ISU Abxis Company Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ISU Abxis Company Limited with three other
companies in this sector in South Korea:
sales of 17.95 billion Korean Won [US$16.80 million]
of which 86%
was The clinical trial agent),
Tego Science Inc
(8.34 billion Korean Won [US$7.81 million]
Cellumed Co Ltd
(9.81 billion Korean Won [US$9.19 million]
ISU Abxis Company Limited reported sales of 19.05 billion Korean Won (US$17.84 million)
December of 2016.
increase of 66.1%
versus 2015, when the company's sales were 11.47 billion Korean Won.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
528.0% in 2016, from
50.30 million Korean Won to 315.88 million Korean Won.